28 October 2024 | Pre-Congress Workshops | Catalonia Barcelona Plaza
29-31 October 2024 | Main Congress Days | Fira de Barcelona Montjuïc
Attendees
Speakers
Exhibitors
Days
Partnering Meetings
Networking Connections
The World Vaccine Congress Europe is the largest and most established European meeting on vaccine R&D
Covering Clinical Development, Bioprocessing & Manufacturing, Cancer Immunotherapy and much more
125+ leading solution providers from across the globe, featuring new ways of thinking and novel partnerships to generate solutions
Networking is at the heart of World Vaccine Congress Europe. Our congress allows you to connect directly with thousands of vaccine experts across 4 days of built-in 1-2-1 networking
Dr. Keirstead is an internationally known stem cell expert and has led therapy development for late stage cancers, immune disorders, motor neuron diseases, spinal cord injury and retinal diseases. He is the CEO of AIVITA Biomedical. He was previously CSO of Caladrius which acquired California Stem...
Dr. Ed Kelley is the Chief Global Health Officer at ApiJectHe recently left his position as the World Health Organization’s Director of Integrated Health Services, where he helped lead the organization’s COVID-19 response, creating WHO’s first public-private collaboration working directly with the...
Antonio Garcia Maldonado is an Principal at SIF. He works on international investments with a focus on biotech in Europe and Israel, and tech-enabled service/product delivery in South Asia and Sub-Saharan Africa. Prior to joining the foundation, Antonio worked in the investment banking division at...
Francesco Pappalardo was born in Catania on 11 March 1975. He graduated in Computer Science with 110/110 cum laude on 2000 at the University of Catania; after graduating, in 2004 he obtained the title of Doctor of Philosophy (PhD) in Computer Science. From 2004 to 2011 he was a research fellow at...
Dr Ewer is an expert in the human immune response to vaccination and specialises in understanding how immunity translates into protective efficacy. She undertook her PhD on the immunology of T cell responses to TB and co-developed a diagnostic assay for the early detection of TB infection. She has...
Dr. Lenny Moise, VP Research, manages client projects and scientific development of the SeromYx Systems Serology platform for clinical research and drug discovery in infectious disease, immuno-oncology, autoimmunity and neurology. Prior to joining SeromYx, Lenny was Director of Vaccine Research at...
Ingrid de Visser - Kamerling (1975) graduated in Medical Biology from Leiden University in 1998. She subsequently worked at CHDR as a project leader and PhD student. She obtained her PhD from Leiden University in 2003 and became a registered clinical pharmacologist in 2005. From 2004 to 2007, she...
Nico holds a degree Business Engineering and obtained a PhD in Operations Research and Operations Management from KU Leuven in 1996. As full professor at KU Leuven, he is holder of the GSK Research Chairs on Access-to-Medicines, the Janssen Pharmaceutica Research Chair on Pandemic Preparedness and...
Join our mailing list to receive exclusive content and offers.
By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.